TrialScientific reports2024

The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial.

Shakiba Shoaei Matin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.